Der er ikke observeret nogen klinisk betydende ændringer i lasofoxifens farmakokinetik i aldersgruppen 40 til 80 år i en farmakokinetisk populationsanalyse.
No clinically meaningful differences in lasofoxifene pharmacokinetic were observed over the age range of 40 to 80 years of age based on the results of a population pharmacokinetic analysis.